These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17266572)

  • 1. Structure and functions of influenza virus neuraminidase.
    Gong J; Xu W; Zhang J
    Curr Med Chem; 2007; 14(1):113-22. PubMed ID: 17266572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in anti-influenza agents with neuraminidase as target.
    Zhang J; Xu W
    Mini Rev Med Chem; 2006 Apr; 6(4):429-48. PubMed ID: 16613580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S; De-Eknamkul W
    Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore model of influenza neuraminidase inhibitors--a systematic review.
    Gong JZ; Liu Y; Xu WF
    Pharmazie; 2009 Oct; 64(10):627-32. PubMed ID: 19947162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of aromatic inhibitors of influenza virus neuraminidase.
    Jedrzejas MJ; Singh S; Brouillette WJ; Laver WG; Air GM; Luo M
    Biochemistry; 1995 Mar; 34(10):3144-51. PubMed ID: 7880809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza neuraminidase.
    Air GM
    Influenza Other Respir Viruses; 2012 Jul; 6(4):245-56. PubMed ID: 22085243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.
    Hurt AC; Okomo-Adhiambo M; Gubareva LV
    Methods Mol Biol; 2012; 865():115-25. PubMed ID: 22528156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza virus neuraminidase: structure, antibodies, and inhibitors.
    Colman PM
    Protein Sci; 1994 Oct; 3(10):1687-96. PubMed ID: 7849585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Amino Acid in the Stalk Domain of N1 Neuraminidase Is Critical for Enzymatic Activity.
    Zanin M; Duan S; Wong SS; Kumar G; Baviskar P; Collin E; Russell C; Barman S; Hause B; Webby R
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity in influenza virus targeted drug design: interaction with human sialidases.
    Chavas LM; Kato R; Suzuki N; von Itzstein M; Mann MC; Thomson RJ; Dyason JC; McKimm-Breschkin J; Fusi P; Tringali C; Venerando B; Tettamanti G; Monti E; Wakatsuki S
    J Med Chem; 2010 Apr; 53(7):2998-3002. PubMed ID: 20222714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.
    Yan ZL; Liu AY; Wei XX; Zhang Z; Qin L; Yu Q; Yu P; Lu K; Yang Y
    Carbohydr Res; 2019 May; 477():32-38. PubMed ID: 30954773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
    Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.
    Shan Y; Ma Y; Wang M; Dong Y
    Curr Med Chem; 2012; 19(34):5885-94. PubMed ID: 22963668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping.
    Brouillette WJ; Atigadda VR; Luo M; Air GM; Babu YS; Bantia S
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1901-6. PubMed ID: 10450950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-guided design of a novel class of benzyl-sulfonate inhibitors for influenza virus neuraminidase.
    Platis D; Smith BJ; Huyton T; Labrou NE
    Biochem J; 2006 Oct; 399(2):215-23. PubMed ID: 16776653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors.
    Yi X; Guo Z; Chu FM
    Bioorg Med Chem; 2003 Apr; 11(7):1465-74. PubMed ID: 12628672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
    Sun J; Cai S; Mei H; Li J; Yan N; Wang Q; Lin Z; Huo D
    Chem Biol Drug Des; 2010 Sep; 76(3):245-54. PubMed ID: 20626407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.